Backstrom Jay T. Insider Trades

Insider Trading History

Track insider trading activity for Backstrom Jay T.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
LAVA Therapeutics NV
LAVA Therapeutics NV LVTX
Director
Holding Value $0 0 shares
Last Trade
Nov 13, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$56.8k 33,390 shares
$1.70
$1.74
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $833k 23,393 shares
Last Trade
Jul 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$849k 23,393 shares
$36.28
$35.59
Scholar Rock Holding
Scholar Rock Holding SRRK
CHIEF EXECUTIVE OFFICER
Holding Value $21.8M 425,561 shares
Last Trade
Mar 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.32M 151,430 shares
$35.15
$51.27
Scholar Rock Holding
Scholar Rock Holding SRRK
CHIEF EXECUTIVE OFFICER
Holding Value $16M 311,991 shares
Last Trade
Feb 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$677k 18,372 shares
$36.83
$51.27
LAVA Therapeutics NV
LAVA Therapeutics NV LVTX
Director
Holding Value $58.1k 33,390 shares
Last Trade
Feb 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.1k 33,390 shares
$0.93
$1.74
Scholar Rock Holding
Scholar Rock Holding SRRK
CHIEF EXECUTIVE OFFICER
Holding Value $16.9M 330,363 shares
Last Trade
Jan 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$986k 22,308 shares
$44.20
$51.27
LAVA Therapeutics NV
LAVA Therapeutics NV LVTX
Director
Holding Value $0 0 shares
Last Trade
Jan 01, 2025 Sale
$69.8k 73,390 shares
$0.95
$1.74
Scholar Rock Holding
Scholar Rock Holding SRRK
CHIEF EXECUTIVE OFFICER
Holding Value $18.1M 352,671 shares
Last Trade
Feb 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$183k 11,614 shares
$15.74
$51.27
Scholar Rock Holding
Scholar Rock Holding SRRK
CHIEF EXECUTIVE OFFICER
Holding Value $18.7M 364,285 shares
Last Trade
Feb 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.5M 285,715 shares
$15.75
$51.27
Scholar Rock Holding
Scholar Rock Holding SRRK
CHIEF EXECUTIVE OFFICER
Holding Value $10.3M 200,000 shares
Last Trade
Feb 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.5M 350,000 shares
$10.00
$51.27
Gemini Therapeutics
Gemini Therapeutics GMTX
Director
Holding Value $0 0 shares
Last Trade
Dec 29, 2022 Sale
$18.9k 14,028 shares
$1.35
$1.35
Gemini Therapeutics
Gemini Therapeutics GMTX
Director
Holding Value $9.45k 7,000 shares
Last Trade
Dec 29, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.45k 7,000 shares
$1.35
$1.35
Scholar Rock Holding
Scholar Rock Holding SRRK
Ceo-elect
Holding Value $51.3M 1,000,000 shares
Last Trade
Sep 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.85M 1,000,000 shares
$8.85
$51.27
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Research And Development
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$21.1M 117,859 shares
$178.75
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Research And Development
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Tender)Reported as Tender on SEC Form 4.
$3.8M 21,233 shares
$178.75
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Research And Development
Holding Value $3.71M 20,781 shares
Last Trade
Jan 29, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.41M 20,896 shares
$115.53
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Research And Development
Holding Value $2.75M 15,372 shares
Last Trade
Jan 04, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$216k 1,735 shares
$124.31
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Research And Development
Holding Value $17.3M 96,963 shares
Last Trade
Jan 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.1M 96,963 shares
$52.61
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
Evp, Research And Development
Holding Value $17M 94,865 shares
Last Trade
Jan 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.89M 111,972 shares
$52.61
$178.75

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up